YU44998B - Process for obtaining 2-oxindole-1-carboxamide compound - Google Patents

Process for obtaining 2-oxindole-1-carboxamide compound

Info

Publication number
YU44998B
YU44998B YU730/85A YU73085A YU44998B YU 44998 B YU44998 B YU 44998B YU 730/85 A YU730/85 A YU 730/85A YU 73085 A YU73085 A YU 73085A YU 44998 B YU44998 B YU 44998B
Authority
YU
Yugoslavia
Prior art keywords
oxindole
obtaining
carboxamide compound
carboxamide
compound
Prior art date
Application number
YU730/85A
Other languages
English (en)
Other versions
YU73085A (en
Inventor
S B Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU73085A publication Critical patent/YU73085A/xx
Publication of YU44998B publication Critical patent/YU44998B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
YU730/85A 1984-05-04 1985-04-30 Process for obtaining 2-oxindole-1-carboxamide compound YU44998B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
YU73085A YU73085A (en) 1988-04-30
YU44998B true YU44998B (en) 1991-06-30

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
YU730/85A YU44998B (en) 1984-05-04 1985-04-30 Process for obtaining 2-oxindole-1-carboxamide compound

Country Status (25)

Country Link
JP (1) JPS60243068A (en:Method)
KR (1) KR870000497B1 (en:Method)
AR (1) AR241159A1 (en:Method)
BG (2) BG60208B2 (en:Method)
CS (1) CS252828B2 (en:Method)
DD (1) DD232916A5 (en:Method)
EG (1) EG17193A (en:Method)
ES (2) ES8609248A1 (en:Method)
FI (1) FI80016C (en:Method)
HU (1) HU196057B (en:Method)
IE (1) IE851103L (en:Method)
IN (1) IN161509B (en:Method)
MA (1) MA20424A1 (en:Method)
MW (1) MW1685A1 (en:Method)
MX (1) MX5839A (en:Method)
NO (1) NO163132C (en:Method)
OA (1) OA08098A (en:Method)
PL (2) PL147508B1 (en:Method)
PT (1) PT80375B (en:Method)
RO (2) RO94455B (en:Method)
RU (1) RU2017729C1 (en:Method)
SU (1) SU1468413A3 (en:Method)
YU (1) YU44998B (en:Method)
ZA (1) ZA853324B (en:Method)
ZW (1) ZW7885A1 (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis

Also Published As

Publication number Publication date
RO94455A (ro) 1988-06-30
FI851756L (fi) 1985-11-05
KR850008154A (ko) 1985-12-13
OA08098A (fr) 1987-03-31
RO91141B (ro) 1987-07-03
KR870000497B1 (ko) 1987-03-12
NO851774L (no) 1985-11-05
EG17193A (en) 1990-08-30
FI80016B (fi) 1989-12-29
RO91141A (ro) 1987-06-30
SU1468413A3 (ru) 1989-03-23
MX5839A (es) 1993-11-01
CS252828B2 (en) 1987-10-15
AR241159A1 (es) 1991-12-30
NO163132B (no) 1990-01-02
YU73085A (en) 1988-04-30
PL253203A1 (en) 1986-06-17
BG60207B2 (en) 1993-12-30
PL145416B1 (en) 1988-09-30
CS320285A2 (en) 1987-03-12
PL147508B1 (en) 1989-06-30
BG60208B2 (en) 1993-12-30
JPS60243068A (ja) 1985-12-03
JPH0335315B2 (en:Method) 1991-05-27
ES551275A0 (es) 1987-07-16
RU2017729C1 (ru) 1994-08-15
ES542813A0 (es) 1986-07-16
FI80016C (fi) 1990-04-10
HU196057B (en) 1988-09-28
AR241159A2 (es) 1991-12-30
RO94455B (ro) 1988-07-01
IN161509B (en:Method) 1987-12-19
PT80375A (en) 1985-05-01
MW1685A1 (en) 1986-09-10
PT80375B (pt) 1987-09-30
MA20424A1 (fr) 1985-12-31
HUT37754A (en) 1986-02-28
IE851103L (en) 1985-11-04
ES8609248A1 (es) 1986-07-16
ZA853324B (en) 1986-12-30
DD232916A5 (de) 1986-02-12
PL257892A1 (en) 1986-10-07
NO163132C (no) 1990-04-11
ES8707182A1 (es) 1987-07-16
FI851756A0 (fi) 1985-05-03
ZW7885A1 (en) 1985-07-24

Similar Documents

Publication Publication Date Title
YU197385A (en) Process for stabilizing nicorandyl compound
PT81225B (en) Process for preparing triazoloquinazoline compounds
YU200985A (en) Process for producing acilated diketonic compounds
YU62385A (en) Process for obtaining 9a-aza-9a-homoeritromicyn derivatives
HUT38339A (en) Process for producing dihydropyridine-carbonyl compounds
YU55685A (en) Process for obtaining hydroxi-4-2h-1-benzothiopyran-2 one
ZA858835B (en) Process for preparing 4-aminodiphenylamines
PT80663B (en) Process for preparing epoxysteroids
HUT38942A (en) Process for preparing substituted 7-oxo-mitosanes
GB2175583A (en) Process for preparing n-acylphenylalanines
YU69785A (en) Process for obtaining l-carnityne
HUT38952A (en) Process for 16alpha-metylation
EP0165595A3 (en) Process for preparing 5-deoxy-l-arabinose
GB2167752B (en) Process for synthesizing diorganomonothiophosphinates
YU64385A (en) Process for preparing bis-chinazolinic compounds
IL76816A (en) Process for preparing 13-hydroxy-5-ketomilbemycin
DE3560035D1 (en) Process for the preparation of 2-methyl-2-alkenals
GB2183670B (en) Process for self-hydrogenation
GB2161802B (en) Process for producing n-chlorosulfenyl compounds
PT80816B (en) Process for preparing pyridazinylimidazolidinone compounds
YU73085A (en) Process for obtaining 2-oxindole-1-carboxamide compound
YU6185A (en) Process for obtaining phenoxi-benzaldeniodic derivatives
YU102587A (en) Process for obtaining substituted ethandiimidamides
DE3563448D1 (en) Process for preparing polyphenylenethers
DE3564569D1 (en) Process for preparing 2-alkyl-5-haloacetylbenzenesulfonamide